Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
AssigneeGenentech, Inc.
InventorsAvi Ashkenazi, Audrey Goddard, Austin Gurney, Scot Marsters, Robert Pitti, William Wood
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel polypeptides having homology to members of the tumor necrosis factor receptor family and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Claims6
1-31. (canceled)
A method of modulating a proinflammatory or autoimmune response in mammalian cells, comprising exposing said cells to an effective amount of PRO364 polypeptide.
A method of modulating a proinflammatory or autoimmune response in mammalian cells, comprising exposing said cells to an effective amount of PRO364 polypeptide, wherein said PRO364 polypeptide is selected from the group consisting of:
- (a) a PRO364 polypeptide comprising the sequence of amino acid residues 1 to 241 of FIG. 2A (SEQ ID NO:3);
- (b) a PRO364 polypeptide encoded by the cDNA in ATCC Deposit No. 209436 (DNA47365-1206);
- (c) a PRO364 polypeptide comprising the sequence of amino acid residues 1 to X of FIG. 2A (SEQ ID NO:3), wherein X is any one of amino acid residues 157-167 of FIG. 2A (SEQ ID NO:3);
- (d) a PRO364 polypeptide comprising the sequence of amino acid residues 26 to 241 of FIG. 2A (SEQ ID NO:3);
- (e) a PRO364 polypeptide comprising the sequence of amino acid residues 26 to X of FIG. 2A (SEQ ID NO:3), wherein X is any one of amino acid residues 157-167 of FIG. 2 (SEQ ID NO:3);
- (f) a fragment of (a), (b), (c), (d), or (e).
Dependencies are inferred from the claim text.